PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz

USPTO PatentsView assignee record - 62 granted patents across 16 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tron—translationale ranks #5,557 of 50,000 tracked US assignees by granted-patent volume, with 62 patents across 16 technology areas.

#5,557
of 50,000 US assignees by volume
Top 18%
by Innovation Score (47.7/100)
21.8
avg claims per patent
+246%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5557 · Foreign Corporation #5,557 · 62 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 62 grants
  • UPPER-Q #5,557/50,000
  • PHOTO-FINISH Scientific Drilling…
  • CPC-FOCUS A61K · 16 areas
  • INNOV-PAR 47.7/100
  • CLAIMS-DENSE 21.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +246% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Scientific Drilling International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Tron—translationale

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #5,557 of 50,000; Innovation Score 47.7/100 sits in the top 18% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Scientific Drilling International, Inc. (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz has been granted 62 US utility patents between 2016 and 2025, placing Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz at #5,557 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz is one of the more focused assignees in the PatentsView dataset. By volume, Tron—translationale sits between Sungwoo Hitech Co., Ltd. (62 patents, rank #5,549) and Typhon Technology Solutions (u.s.), Llc (62 patents, rank #5,557) - the closest US assignees by grant volume. The composite Innovation Score of 47.7/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 45 grants, compared with 13 in the 2015–2019 window, a +246% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz's 21.8 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 16 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Tron—translationale's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tron—translationale holds 62 patents at rank #5,553, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tron—translationale

By rank, the assignees closest to #5,553 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Tron—translationale's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tron—translationale, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Vanrx Pharmasystems Inc. 48 Chimei Corporation 48 Elevance Renewable Sciences, Inc. 48 Streamlight, Inc. 48

Similar claim depth

Nearest assignees by average claims per patent (21.8 here).

Luxtera, Inc. 21.8 avg Carl Zeiss SMT Gmbh 21.8 avg Skyhook Wireless, Inc. 21.8 avg Lagree Technologies, Inc. 21.8 avg

Tron—translationale's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 4 6.5%
2017 1 1.6%
2018 5 8.1%
2019 3 4.8%
2020 15 24.2%
2021 7 11.3%
2022 10 16.1%
2023 6 9.7%
2024 7 11.3%
2025partial year 4 6.5%

Which technologies does Tron—translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz patent most?

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#5,557

of 50,000 tracked assignees

Innovation Score

47.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.